Overall (N = 157) | VISITAG (-) (N = 95) | VISITAG (+) (N = 62) | P value | |
---|---|---|---|---|
Age | 56.7 ± 10.9 | 55.6 ± 11.2 | 58.5 ± 10.2 | 0.099 |
Men | 115 (73.2) | 70 (73.7) | 45 (72.6) | > 0.99 |
BMI | 24.6 ± 3.4 | 24.8 ± 3.1 | 24.3 ± 3.8 | 0.339 |
Previous medical history | ||||
Hypertension | 51 (32.5) | 32 (33.7) | 19 (30.6) | 0.823 |
Diabetes | 14 (8.9) | 8 (8.4) | 6 (9.7) | > 0.99 |
Congestive heart failure | 3 (1.9) | 2 (2.1) | 1 (1.6) | > 0.99 |
Vascular disease | 4 (2.5) | 3 (3.2) | 1 (1.6) | 0.934 |
Ischemic stroke/TIA | 16 (10.2) | 6 (6.3) | 10 (16.1) | 0.086 |
CHA2DS2-VASc score | 1.2 ± 1.4 | 1.1 ± 1.4 | 1.4 ± 1.3 | 0.284 |
CHA2DS2-VASc score ≥ 2 | 54 (34.4) | 28 (29.5) | 26 (41.9) | 0.151 |
Left ventricular ejection fraction, % | 61.0 ± 6.3 | 61.0 ± 6.1 | 60.9 ± 6.7 | 0.905 |
Left atrial size, mm | 39.6 ± 5.5 | 39.4 ± 4.9 | 39.9 ± 6.3 | 0.554 |
Left atrial volume, ml | 112.5 ± 32.9 | 116.6 ± 31.8 | 108.0 ± 33.8 | 0.147 |
Amiodarone | 14 (8.9) | 8 (8.4) | 6 (9.7) | >0.99 |
Class 1C drug | 120 (76.4) | 68 (71.6) | 52 (83.9) | 0.114 |
Beta-blocker | 47 (29.9) | 22 (23.2) | 25 (40.3) | 0.034 |
Calcium channel blockers | 47 (29.9) | 32 (33.7) | 15 (24.2) | 0.275 |
Digoxin | 10 (6.4) | 2 (2.1) | 8 (12.9) | 0.018 |